Historical record - last NADAC publication: 1/1/2016
Product Information
KINERET 100 MG/0.67 ML SYRINGE is a brand product labeled by Swedish Orphan Biovitrum AB (publ), priced at $192.3106 per ML under NDC 66658023428. Its NADAC has been published 161 times since Dec 18, 2013.
Strength
100 mg/.67mL
Manufacturer
Swedish Orphan Biovitrum AB (publ)NDC
66658023428
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2016
Active Ingredients
ANAKINRAApproval Type
Biologic (BLA)
FDA Application
BLA103950On Market Since
12/15/2009
Pharmacological Classes
Price Statistics
The NADAC for KINERET 100 MG/0.67 ML SYRINGE has been published 161 times since Dec 18, 2013, and over the history we have for it it has risen 41.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $192.3106 per ML |
|---|---|
| All-time high | $192.3106 (Jan 11, 2017) |
| All-time low | $136.2476 (Dec 18, 2013) |
| Median price | $176.4317 |
| Average price | $171.3253 |
| Largest weekly change | +9.0% (Sep 10, 2014) |
| Weeks tracked | 161 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the anakinra market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KINERET 100 MG/0.67 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for KINERET 100 MG/0.67 ML SYRINGE, manufactured by Swedish Orphan Biovitrum AB (publ), is $192.3106 per ML (NDC 66658023428), effective Jan 11, 2017.
How has the price of KINERET 100 MG/0.67 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for KINERET 100 MG/0.67 ML SYRINGE has risen 41.1%. It has been tracked across 161 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for KINERET 100 MG/0.67 ML SYRINGE?
Since Dec 18, 2013, the NADAC for KINERET 100 MG/0.67 ML SYRINGE has ranged from a low of $136.2476 (Dec 18, 2013) to a high of $192.3106 (Jan 11, 2017), with a median of $176.4317 per ML.
Are there cheaper alternatives to KINERET 100 MG/0.67 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KINERET 100 MG/0.67 ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures KINERET 100 MG/0.67 ML SYRINGE?
KINERET 100 MG/0.67 ML SYRINGE (NDC 66658023428) is labeled by Swedish Orphan Biovitrum AB (publ), and CMS classifies it as a brand product.
Related Drugs
Same classification